NVO
Novo-Nordisk A/S
Healthcare •
Drug Manufacturers - General •
stocks •
XNYS
• usd
$47.19
$-3.11
(-6.18%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $209.69B | EPS (ttm) | $3.64 | Current Price | $47.19 |
| Enterprise Value | $292.14B | Forward EPS | $3.91 | Previous Close | $50.30 |
| P/E Ratio | 12.96 | ROA | 21.11% | 52W High | $93.80 |
| Forward P/E | 12.06 | ROE | 71.47% | 52W Low | $43.08 |
| PEG Ratio | - | Gross Margin | 83.44% | 50 Day Avg | $53.25 |
| P/S Ratio | 0.66 | Operating Margin | 44.35% | 200 Day Avg | $58.77 |
| P/B Ratio | 7.81 | Profit Margin | 32.88% | Volume | 46.53M |
| EV/EBITDA | 1.76 | Current Ratio | 0.78 | Avg Volume | 21.36M |
| EV/Sales | 0.93 | Quick Ratio | 0.53 | Beta | 0.40 |
| Employees | 78.55K | Debt/Equity | 59.57 | Shares Outstanding | 3.37B |
| Sector | Healthcare | Total Debt | $101.21B | Float Shares | 3.19B |
| Industry | Drug Manufacturers - General | Total Cash | $32.58B | Short Float | 0.84% |
| Optionable | Yes | Cash/Share | $7.33 | Short Ratio | 1.45 |
| Dividend Yield | 343.00% | Book Value/Share | $6.04 | % Held by Insiders | - |
| Target Price | $58.53 | Revenue (TTM) | $315.60B | % Held by Institutions | 9.13% |